Limits...
Performance and characteristics of the Newborn Hearing Screening Programme in England: The first seven years.

Wood SA, Sutton GJ, Davis AC - Int J Audiol (2015)

Bottom Line: For bilateral PCHL in the 12/13 birth cohort the median age is nine days at screen completion, 30 days at entry into follow up, 49 days at confirmation, 50 days at referral to early intervention, and 82 days at hearing-aid fitting.The yield of bilateral PCHL from the screen is about 1/1000 as expected.The age of identification and management is well within the first six months of life, although there remains scope for further improvement with respect to timely entry into follow up.

View Article: PubMed Central - PubMed

Affiliation: * NHS Newborn Hearing Screening Programme, Public Health England , London , UK.

ABSTRACT

Objective: To assess the performance of the universal newborn hearing screen in England.

Design: Retrospective analysis of population screening records.

Study sample: A total of 4 645 823 children born 1 April 2004 to 31 March 2013.

Results: 97.5% of the eligible population complete screening by 4/5 weeks of age and 98.9% complete screening by three months of age. The refer rate for the 12/13 birth cohort is 2.6%. The percentage of screen positive (i.e. referred) babies commencing follow up by four weeks of age and six months of age is 82.5% and 95.8% respectively. The yield of bilateral PCHL from the screen is around 1/1000. For bilateral PCHL in the 12/13 birth cohort the median age is nine days at screen completion, 30 days at entry into follow up, 49 days at confirmation, 50 days at referral to early intervention, and 82 days at hearing-aid fitting.

Conclusion: The performance of the newborn hearing screening programme has improved continuously. The yield of bilateral PCHL from the screen is about 1/1000 as expected. The age of identification and management is well within the first six months of life, although there remains scope for further improvement with respect to timely entry into follow up.

No MeSH data available.


Percentage of referred babies entering follow-up within four weeks of screen completion/by 44 weeks GA, and by six months of age.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4487563&req=5

Figure 0003: Percentage of referred babies entering follow-up within four weeks of screen completion/by 44 weeks GA, and by six months of age.

Mentions: Figure 3 shows the proportion of referred babies attending a follow up appointment within four weeks of the referral decision or by 44 weeks GA. The purpose of the latter condition is to allow some leeway for audiological assessment to be delayed for premature babies to allow them to reach full term. Performance early in the programme was initially poor but has improved considerably over the time period and reached 82.5 % for the 12/13 birth cohort. It has not yet reached the quality standard target of 90%. Figure 3 also shows the proportion of referred babies that have attended an audiological assessment by six months of age. This has improved gradually and reaches 95.8% for the 12/13 birth cohort.


Performance and characteristics of the Newborn Hearing Screening Programme in England: The first seven years.

Wood SA, Sutton GJ, Davis AC - Int J Audiol (2015)

Percentage of referred babies entering follow-up within four weeks of screen completion/by 44 weeks GA, and by six months of age.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4487563&req=5

Figure 0003: Percentage of referred babies entering follow-up within four weeks of screen completion/by 44 weeks GA, and by six months of age.
Mentions: Figure 3 shows the proportion of referred babies attending a follow up appointment within four weeks of the referral decision or by 44 weeks GA. The purpose of the latter condition is to allow some leeway for audiological assessment to be delayed for premature babies to allow them to reach full term. Performance early in the programme was initially poor but has improved considerably over the time period and reached 82.5 % for the 12/13 birth cohort. It has not yet reached the quality standard target of 90%. Figure 3 also shows the proportion of referred babies that have attended an audiological assessment by six months of age. This has improved gradually and reaches 95.8% for the 12/13 birth cohort.

Bottom Line: For bilateral PCHL in the 12/13 birth cohort the median age is nine days at screen completion, 30 days at entry into follow up, 49 days at confirmation, 50 days at referral to early intervention, and 82 days at hearing-aid fitting.The yield of bilateral PCHL from the screen is about 1/1000 as expected.The age of identification and management is well within the first six months of life, although there remains scope for further improvement with respect to timely entry into follow up.

View Article: PubMed Central - PubMed

Affiliation: * NHS Newborn Hearing Screening Programme, Public Health England , London , UK.

ABSTRACT

Objective: To assess the performance of the universal newborn hearing screen in England.

Design: Retrospective analysis of population screening records.

Study sample: A total of 4 645 823 children born 1 April 2004 to 31 March 2013.

Results: 97.5% of the eligible population complete screening by 4/5 weeks of age and 98.9% complete screening by three months of age. The refer rate for the 12/13 birth cohort is 2.6%. The percentage of screen positive (i.e. referred) babies commencing follow up by four weeks of age and six months of age is 82.5% and 95.8% respectively. The yield of bilateral PCHL from the screen is around 1/1000. For bilateral PCHL in the 12/13 birth cohort the median age is nine days at screen completion, 30 days at entry into follow up, 49 days at confirmation, 50 days at referral to early intervention, and 82 days at hearing-aid fitting.

Conclusion: The performance of the newborn hearing screening programme has improved continuously. The yield of bilateral PCHL from the screen is about 1/1000 as expected. The age of identification and management is well within the first six months of life, although there remains scope for further improvement with respect to timely entry into follow up.

No MeSH data available.